If Phase III data replicate the strong Phase II results, atacicept could emerge as a leading biologic in IgAN, particularly for patients with high-risk disease or inadequate response to steroids
The medication is starting to interact with your GLP-1 receptors at a therapeutically meaningful level, and the food noise that many people describe, that constant background hum of thinking about eating, often begins to quiet
The FDA has received adverse-event reports involving compounded semaglutide and tirzepatide, including dosing errors and events requiring medical attention
As Ozempics Popularity Soars, Heres What to Know About Semaglutide and Weight Loss
Clinicians choose peptides based on whether you are dealing with things like fatigue, insomnia, or age-related hormone decline
Ill be watching this space closely and translating the science into real-world guidance as more data comes out